0
May 1994, Vol 51, No. 5 >
Article | May 1994

Ceftriaxone in Amyotrophic Lateral Sclerosis

Forbes H. Norris, MD
Arch Neurol. 1994;51(5):447-447. doi:10.1001/archneur.1994.00540170019006
Text Size: A A A
Published online
Article
References
Comments

Smith1 reported on improvement in one case of amyotrophic lateral sclerosis (ALS) during administration of the cyclosporin antibiotic, ceftriaxone. The patient relapsed when ceftriaxone treatment was stopped, but failed to improve during a second course of the antibiotic.2

Robberecht3 found no benefit from the administration of ceftriaxone to six patients with ALS.

I also investigated ceftriaxone treatment in recent patients with ALS. All of them met the World Federation of Neurology criteria4 for probable or definite ALS. The hospital files were searched for patients with ALS who were admitted from 1989 through 1992 and treated with antibiotics for any reason. There were 11 patients whose treatment for infection, usually aspiration pneumonitis, included full therapeutic doses of a second- or third-generation cephalosporin, which in six cases was ceftriaxone, administered twice in two patients. There was a total of 18 cephalosporin courses in the 11 cases, which all

REFERENCES

1 +
Smith LG.  Improvement of patients with amyotrophic lateral sclerosis given ceftriaxone . Lancet . 1992;;339:1417.
2 +
Smith LG.  Failure of ceftriaxone for amyotrophic lateral sclerosis . Lancet . 1992;; 340:379.
3 +
Robberecht W.  Lack of improvement with ceftriaxone in motoneuron disease . Lancet . 1992;;340:1096-1097.
4 +
World Federation of Neurology.  Criteria for diagnosis of amyotrophic lateral sclerosis . World Neurol . 1990;;5:12.1

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

1 +
Smith LG.  Improvement of patients with amyotrophic lateral sclerosis given ceftriaxone . Lancet . 1992;;339:1417.
2 +
Smith LG.  Failure of ceftriaxone for amyotrophic lateral sclerosis . Lancet . 1992;; 340:379.
3 +
Robberecht W.  Lack of improvement with ceftriaxone in motoneuron disease . Lancet . 1992;;340:1096-1097.
4 +
World Federation of Neurology.  Criteria for diagnosis of amyotrophic lateral sclerosis . World Neurol . 1990;;5:12.1

Correspondence

Submit a Letter
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general journals
BMJ 2010;341:c5893-c1494.
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

© 2012 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems